| DATE |
SPEAKER |
TITLE |
| Thursday January 12 |
Rita Young, Ph.D. Associate Chief of Staff for Research Va Medical Center Professor of Medicine and Otolaryngology MUSC |
Translating studies on cancer progression into therapeutic strategies. (Associate Provost Candidate) |
| Tuesday January 17 SEI 809 |
Kenneth Ramos, Ph.D. Distinguished Professor and Chairman Biochemistry and Molecular Biology Director, Center for Genetics and Molecular Medicine University of Louisville Health Sciences Center |
Transcriptional
control of LINE-1 retrotransposons in mammalian cells: implications in atherosclerosis
and cancer. (Associate Provost Candidate) |
| January 23 | Steve Ladish, M.D. Bosworth Chair for Cancer Biology Director, Center for Cancer and Immunology Research Children's National Medical Center Emory University |
Tumor gangliosides, cell signaling, and tumor progression. (Associate Provost Candidate) |
| Tuesday January 24 1:00 PM QF 302A |
Bradford Gibson, Ph.D. Professor and Director Chemistry Core Buck Institute for Age Research |
Mitochondrial proteomics, aging and neurodegenerative disease. |
| Thursday January 26 |
Michael Dockter, Ph.D. Professor of Medicine Associate Dean for Research and Administration University of Tennessee Health Sciences Center |
Prenatal genetic diagnosis of fetal cells from maternal blood. (Associate Provost Candidate) |
| January 30 | Mark Kindy, Ph.D. Director, Neuroscience Institute Director, Phenomics Center MUSC |
A tale of two receptors:
mechanisms and therapeutics in Alzheimer's disease. (Associate Provost Candidate) |
| February 7 Tuesday QF 302A |
Mark G. Clemens, Ph.D. Professor and Vice Chair Department of Biology UNC Charlotte |
Endothelin / eNOS interactions in the liver following inflammatory stress. |
| February 13 | David Basile, Ph.D. Associate Professor Cell and Integrative Physiology Indiana Univeristy |
Acute renal failure and the development of chronic disease: implications for altered vascular regulation. |
| February 20 | Joseph Senn, Ph.D. Assistant Professor Pediatric Endocrinology and Pharmacology MUSC |
Type 2 diabetes: cause and effect. |
| March 6 BSB 202 |
Adam VanWert Graduate Student Pharmaceutical Sciences |
In vivo implications of organic anion transporter 3 knockout. |
| March 20 | Dan Liebler, Ph.D. Professor of Biochemistry and Pharmacology Director, Proteomics Laboratory Vanderbilt University |
Proteomic analysis of protein damage in chemical toxicity and oxidative stress. |
| March 27 | Mark Hallman Graduate Student Pharmacology |
In vitro transdifferentiation of renal proximal tubular cells following hydrogen peroxide-induced injury: a role for the EGF receptor. |
| April 3 Seminar Cancelled |
Lakshmi Kotra, Ph.D. Scientist, Toronto General Research Institute Director, Molecular Design and Information Technology Center |
Design of small molecule insulin mimetics: a rational approach. |
| Friday April 7 12 noon BSB 402 |
Xianquan Zhan, M.D., Ph.D. Assistant Professor The Charles B. Stout Neuroscience Mass Spectrometry Laboratory University of Tennessee Health Science Center |
Human pituitary tumor proteomics. |
| April 10 | Gilbert Kinsey Graduate Student Pharmaceutical Sciences |
Identification and characterization of iPLA2 gamma in renal cell mitochondria. |
| April 17 | Gloriane Schnabolk Graduate Student Pharmaceutical Sciences |
The novel murine organic anion transporter mOat6 (Slc22a20) mediates the transport of estrone sulfate. |
| April 24 | No Seminar |
|
| May 1 | Ryan Monfeli Graduate Student Pharmaceutical Sciences |
Targeting IdeR as a potential therapy against Mycobacterium tuberculosis infections. |
| May 8 | Scott Eblen, Ph.D. Assistant Professor Pharmacology and Experimental Therapeutics MUSC |
MAP kinase signaling in ovarian cancer. |
| May 15 |
Jennifer Isaacs, Ph.D. Assistant Professor Pharmacology and Experimental Therapeutics MUSC |
Inhibition of the Hsp90 chaperone as a potent anticancer therapeutic. |
| May 22 |
No seminar |
|
| June 5 |
No seminar |
|
| June 12 |
Giuseppe Gumina, Ph.D. Assistant Professor Pharmaceutical Sciences |
Adenosine receptors as therapeutic targets. |
| June 26 |
Carola Neumann, M.D. Assistant Professor Pharmacology and Experimental Therapeutics MUSC |
Tumorigenesis and oxidative stress: a role for the antioxidant Prdx1 in tumor suppression. |